Literature DB >> 19298935

Do randomized trials of thrombolysis versus open revascularization still apply to current management: what has changed?

Anthony J Comerota1, Marilyn H Gravett.   

Abstract

Several randomized trials of catheter-directed thrombolysis versus operative revascularization in patients with acute lower extremity ischemia were performed in the mid-1990 s. Although the outcomes of these trials were not definitive, they did provide insight into potential uses and techniques of catheter-directed thrombolysis and lytic agents. This article reviews the outcomes of these randomized trials and describes advances in thrombolytic techniques and technology, including percutaneous mechanical thrombectomy devices and innovative catheter designs that accelerate lysis and the development of direct-acting lytic agents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19298935     DOI: 10.1053/j.semvascsurg.2009.01.003

Source DB:  PubMed          Journal:  Semin Vasc Surg        ISSN: 0895-7967            Impact factor:   1.000


  4 in total

1.  Acute limb ischemia: surgical thromboembolectomy and the clinical course of arterial revascularization at ankle.

Authors:  Ha Song Shin; Kyu-Hyouck Kyoung; Byoung Jo Suh; Si-Youl Jun; Jong Kwon Park
Journal:  Int J Angiol       Date:  2013-06

2.  Endovascular versus surgical treatment for acute limb ischemia: a systematic review and meta-analysis of clinical trials.

Authors:  Tariq H Enezate; Jad Omran; Ehtisham Mahmud; Mitul Patel; Mazen S Abu-Fadel; Christopher J White; Ashraf S Al-Dadah
Journal:  Cardiovasc Diagn Ther       Date:  2017-06

3.  Endovascular approach for acute limb ischemia without thrombolytic therapy.

Authors:  Keisuke Fukuda; Yoshiaki Yokoi
Journal:  Ther Adv Cardiovasc Dis       Date:  2020 Jan-Dec

4.  Open or endovascular revascularization in the treatment of acute lower limb ischaemia.

Authors:  O Grip; A Wanhainen; K Michaëlsson; L Lindhagen; M Björck
Journal:  Br J Surg       Date:  2018-07-25       Impact factor: 6.939

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.